These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8221048)

  • 1. Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis.
    Miller DH; Barkhof F; Nauta JJ
    Brain; 1993 Oct; 116 ( Pt 5)():1077-94. PubMed ID: 8221048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between gadolinium-enhanced 2D T1-weighted gradient-echo and spin-echo sequences in the detection of active multiple sclerosis lesions on 3.0T MRI.
    Aymerich FX; Auger C; Alcaide-Leon P; Pareto D; Huerga E; Corral JF; Mitjana R; Sastre-Garriga J; Montalban X; Rovira A
    Eur Radiol; 2017 Apr; 27(4):1361-1368. PubMed ID: 27456965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A preliminary study into the sensitivity of disease activity detection by serial weekly magnetic resonance imaging in multiple sclerosis.
    Lai M; Hodgson T; Gawne-Cain M; Webb S; MacManus D; McDonald WI; Thompson AJ; Miller DH
    J Neurol Neurosurg Psychiatry; 1996 Mar; 60(3):339-41. PubMed ID: 8609517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined gadolinium-enhanced and fat-saturation MR imaging of renal masses.
    Semelka RC; Hricak H; Stevens SK; Finegold R; Tomei E; Carroll PR
    Radiology; 1991 Mar; 178(3):803-9. PubMed ID: 1994422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity of contrast enhanced MRI in multiple sclerosis. Effects of gadolinium dose, magnetization transfer contrast and delayed imaging.
    Silver NC; Good CD; Barker GJ; MacManus DG; Thompson AJ; Moseley IF; McDonald WI; Miller DH
    Brain; 1997 Jul; 120 ( Pt 7)():1149-61. PubMed ID: 9236628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity.
    Barkhof F; Scheltens P; Frequin ST; Nauta JJ; Tas MW; Valk J; Hommes OR
    AJR Am J Roentgenol; 1992 Nov; 159(5):1041-7. PubMed ID: 1414773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI evidence of acute inflammation in leukocortical lesions of patients with early multiple sclerosis.
    Maranzano J; Rudko DA; Nakamura K; Cook S; Cadavid D; Wolansky L; Arnold DL; Narayanan S
    Neurology; 2017 Aug; 89(7):714-721. PubMed ID: 28724581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Unenhanced and Gadolinium-Enhanced Imaging in Multiple Sclerosis: Is Contrast Needed for Routine Follow-Up MRI?
    Sadigh G; Saindane AM; Waldman AD; Lava NS; Hu R
    AJNR Am J Neuroradiol; 2019 Sep; 40(9):1476-1480. PubMed ID: 31439627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gadolinium-pentetic acid magnetic resonance imaging in patients with relapsing remitting multiple sclerosis.
    Capra R; Marcianò N; Vignolo LA; Chiesa A; Gasparotti R
    Arch Neurol; 1992 Jul; 49(7):687-9. PubMed ID: 1497493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trials.
    Filippi M; Rovaris M; Capra R; Gasperini C; Yousry TA; Sormani MP; Prandini F; Horsfield MA; Martinelli V; Bastianello S; Kühne I; Pozzilli C; Comi G
    Brain; 1998 Oct; 121 ( Pt 10)():2011-20. PubMed ID: 9798753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple sclerosis: serial study of gadolinium-enhanced MR imaging.
    Grossman RI; Braffman BH; Brorson JR; Goldberg HI; Silberberg DH; Gonzalez-Scarano F
    Radiology; 1988 Oct; 169(1):117-22. PubMed ID: 3420246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A longitudinal brain MRI study comparing the sensitivities of the conventional and a newer approach for detecting active lesions in multiple sclerosis.
    Filippi M; Mastronardo G; Bastianello S; Rocca MA; Rovaris M; Gasperini C; Pozzilli C; Comi G
    J Neurol Sci; 1998 Jul; 159(1):94-101. PubMed ID: 9700710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential diagnosis of hepatic neoplasms: spin echo versus gadolinium-diethylenetriaminepentaacetate-enhanced gradient echo imaging.
    Abbas YA; Kressel HY; Wehrli FW; Gefter WB; Dinsmore BJ; Chan TW; Oleaga L; Milestone BN; Outwater EK
    Magn Reson Q; 1991 Oct; 7(4):275-92. PubMed ID: 1790113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of delayed gadolinium-enhanced MRI in multiple sclerosis.
    Filippi M; Yousry T; Rocca MA; Fesl G; Voltz R; Comi G
    Acta Neurol Scand; 1997 Jun; 95(6):331-4. PubMed ID: 9228265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: implications for clinical trials and natural history.
    Harris JO; Frank JA; Patronas N; McFarlin DE; McFarland HF
    Ann Neurol; 1991 May; 29(5):548-55. PubMed ID: 1859184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between inflammation and atrophy in clinically isolated syndromes suggestive of multiple sclerosis: a monthly MRI study after triple-dose gadolinium-DTPA.
    Paolillo A; Piattella MC; Pantano P; Di Legge S; Caramia F; Russo P; Lenzi GL; Pozzilli C
    J Neurol; 2004 Apr; 251(4):432-9. PubMed ID: 15083288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble E-selectin in multiple sclerosis: raised concentrations in patients with primary progressive disease.
    Giovannoni G; Thorpe JW; Kidd D; Kendall BE; Moseley IF; Thompson AJ; Keir G; Miller DH; Feldmann M; Thompson EJ
    J Neurol Neurosurg Psychiatry; 1996 Jan; 60(1):20-6. PubMed ID: 8558145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of contrast-enhanced and non-contrast-enhanced MRI in the follow-up of multiple sclerosis.
    Zarei F; Ghaedian M; Ghaedian T
    Acta Radiol; 2021 Jul; 62(7):916-921. PubMed ID: 32762243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detecting new lesion formation in multiple sclerosis: the relative contributions of monthly dual-echo and T1-weighted scans after triple-dose gadolinium.
    Filippi M; Mastronardo G; Rocca MA; Capra R; Gasperini C; Rovaris M; Bastianello S; Comi G
    Eur Neurol; 1998 Oct; 40(3):146-50. PubMed ID: 9748672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.